Alkem Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	142,527	129,645	126,676	115,993	106,342	88,650
Revenue Growth (YoY)	11.73%	2.34%	9.21%	9.07%	19.96%	6.24%
Cost of Revenue	52,854	49,255	50,642	50,207	42,806	35,751
Gross Profit	89,673	80,391	76,034	65,785	63,536	52,899
Selling, General & Admin	35,296	32,422	30,324	29,726	25,769	19,807
Other Operating Expenses	25,618	22,879	23,041	19,760	17,305	13,617
Operating Expenses	64,802	58,873	56,359	52,589	46,103	36,160
Operating Income	24,871	21,518	19,676	13,196	17,432	16,739
Interest Expense	-1,184	-1,048	-970.8	-809.2	-308.9	-398.7
Interest & Investment Income	3,588	3,588	2,758	1,711	1,227	901.2
Earnings From Equity Investments	-20.2	-6.2	-	-	-	-
Currency Exchange Gain (Loss)	380	380	-335.1	-188.6	-16.5	458.4
Other Non Operating Income (Expenses)	594.6	239.6	179.2	-12.8	-24.2	-36.7
EBT Excluding Unusual Items	28,230	24,671	21,307	13,897	18,309	17,664
Gain (Loss) on Sale of Investments	528.9	528.9	151.7	308.6	114.5	369.5
Gain (Loss) on Sale of Assets	46	46	-31.8	-123.6	19.7	388
Asset Writedown	-137.3	-137.3	-576.5	-1,051	-11.2	-
Other Unusual Items	-243.5	155.1	-618.6	17.4	10.5	-
Pretax Income	28,424	25,264	20,231	13,048	18,443	18,421
Income Tax Expense	4,199	3,110	2,117	2,980	1,640	2,243
Earnings From Continuing Operations	24,224	22,154	18,115	10,068	16,803	16,178
Minority Interest in Earnings	-512.4	-499	-156.9	-226.4	-347	-327.5
Net Income	23,712	21,655	17,958	9,842	16,456	15,850
Net Income to Common	23,712	21,655	17,958	9,842	16,456	15,850
Net Income Growth	10.13%	20.59%	82.47%	-40.20%	3.82%	40.63%
Shares Outstanding (Basic)	120	120	120	120	120	120
Shares Outstanding (Diluted)	120	120	120	120	120	120
EPS (Basic)	198.31	181.11	150.19	82.31	137.63	132.57
EPS (Diluted)	198.31	181.11	150.19	82.31	137.63	132.57
EPS Growth	10.12%	20.59%	82.47%	-40.20%	3.82%	40.63%
Free Cash Flow	-	12,372	16,888	14,496	7,721	10,700
Free Cash Flow Per Share	-	103.48	141.24	121.24	64.58	89.49
Dividend Per Share	51.000	45.000	40.000	25.000	34.000	30.000
Dividend Growth	21.43%	12.50%	60.00%	-26.47%	13.33%	20.00%
Gross Margin	62.92%	62.01%	60.02%	56.72%	59.75%	59.67%
Operating Margin	17.45%	16.60%	15.53%	11.38%	16.39%	18.88%
Profit Margin	16.64%	16.70%	14.18%	8.48%	15.47%	17.88%
Free Cash Flow Margin	-	9.54%	13.33%	12.50%	7.26%	12.07%
EBITDA	28,353	24,619	22,268	15,893	20,122	19,147
EBITDA Margin	19.89%	18.99%	17.58%	13.70%	18.92%	21.60%
D&A For EBITDA	3,482	3,101	2,592	2,697	2,690	2,408
EBIT	24,871	21,518	19,676	13,196	17,432	16,739
EBIT Margin	17.45%	16.60%	15.53%	11.38%	16.39%	18.88%
Effective Tax Rate	14.77%	12.31%	10.46%	22.84%	8.89%	12.18%
Revenue as Reported	147,819	134,583	129,784	118,153	107,968	90,982

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.